Abstract
The naturally occurring cyclic tetrapeptide, chlamydocin, originally isolated from fungus Diheterospora chlamydosphoria, consists of α-aminoisobutyric acid, l-phenylalanine, d-proline and an unusual amino acid (S)-2-amino-8-((S)-oxiran-2-yl)-8-oxooctanoic acid (Aoe) and inhibits the histone deacetylases (HDACs), a class of regulatory enzymes. The epoxyketone moiety of Aoe is the key functional group for inhibition. The cyclic tetrapeptide scaffold is supposed to play important role for effective binding to the surface of enzymes. In place of the epoxyketone group, hydroxamic acid and sulfhydryl group have been applied to design inhibitor ligands to zinc atom in catalytic site of HDACs. In the research for more potent HDAC inhibitors, we replaced the epoxyketone moiety of Aoe with different functional groups and synthesized a series of chlamydocin analogs as HDAC inhibitors. Among the functional groups, methoxymethylketone moiety showed as potent inhibition as the hydroxamic acid. On the contrary, we confirmed that borate, trifruoromethylketone, and 2-aminoanilide are almost inactive in HDAC inhibition.
Similar content being viewed by others
References
Bhuiyan MPI, Kato T, Okauchi T et al (2006) Chlamydocin analogs bearing carbonyl group as possible ligand toward zinc atom in histone deacetylases. Bioorg Med Chem 14:3438–3446. doi:10.1016/j.bmc.2005.12.063
Butler KV, Kalin J, Brochier C, Vistoli G, Langley B, Kozikowski AP (2010) Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastin A. J Am Chem Soc 132:10842–10846. doi:10.1021/ja102758v
Closse A, Hugenin R (1974) Isolierung und Strukturaufklärung von Chlamydocin. Helv Chim Acta 57:533–545. doi:10.1002/hlca.19740570306
Darkin-Rattray SJ, Gurnett AM, Myers RW et al (1996) Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. Proc Natl Acad Sci USA 93:13143–13147
Furumai R, Komatsu Y, Nishino N et al (2001) Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. Proc Natl Acad Sci USA 98:87–92
Furumai R, Matsuyama A, Kobashi M (2002) FK228 (depsipeptide) as a natural prodrug that inhibits class1 histone deacetylases1. Cancer Res 62:4916–4921
Grozinger CM, Schreiber SL (2002) Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chem Biol 9:3–16
Han JW, Ahn SH, Park SH et al (2000) Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21waf1/cip1 and gelsolin1. Cancer Res 60:6068–6074
Hassig CA, Schreiber SL (1997) Nuclear histone acetylases and deacetylases and transcriptional regulation: HATS off to HDACs. Curr Opin Chem Biol 1:300–308
Hirota A, Suzuki A, Aizawa K, Tamura S (1973a) Structure of Cyl-2, a novel cyclotetrapeptide from Cylindrocladium scoparium. Agric Biol Chem 37:955–956
Hirota A, Suzuki A, Suzuki H, Tamura S (1973b) Isolation and biological activity of cyl-2, a metabolite of Cylindrocladium scoparium. Agric Biol Chem 37:643–647
Hirota A, Suzuki A, Tamura S (1973c) Characterization of four amino acids constituting cyl-2, a metabolite from Cylindrocladium scoparium. Agric Biol Chem 37:1185–1189
Jose B, Oniki Y, Kato T et al (2004) Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones. Bioorg Med Chem Lett 14:5343–5346. doi:10.1016/j.bmcl.2004.08.016
Kapustin GV, Fejér G, Jennifer L, Gronlund JL et al (2003) Phosphorus-based SAHA analogues as histone deacetylase inhibitors. Org Lett 5:3053–3056. doi:10.1021/ol035056n
Kijima M, Yoshida M, Suguta K et al (1993) Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J Biol Chem 268:22249–22435
Kouzarides T (1999) Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev 9:40–48
Meinke PT, Liberator P (2001) Histone deacetylase: a target for antiproliferative and antiprotozoal agents. Curr Med Chem 8:211–235
Nishino N, Jose B, Okamura S et al (2003) Cyclic tetrapeptides bearing a sulfhydryl group potently inhibit histone deacetylases. Org Lett 5:5079–5082. doi:10.1021/ol036098e
Nishino N, Yoshikawa D, Watanabe LA et al (2004) Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand. Bioorg Med Chem lett 14:2427–2431. doi:10.1016/j.bmcl.2004.03.018
Saito A, Yamashita T, Mariko Y (1999) A synthetic inhibitor of histone deacetylase, MS-27–275, with marked in vivo antitumor activity against human tumors. Proc Natl Acad Sci USA 96:4592–4597
Suzuki T, Ando T, Tsuchiya K et al (1999) Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives. J Med Chem 42:3001–3003. doi:10.1021/jm980565u
Suzuki T, Kouketsu A, Matsuura A et al (2004) Thiol-based SAHA analogues as potent histone deacetylase Inhibitors. Bioorg Med Chem Lett 14:3313–3317. doi:10.1016/j.bmcl.2004.03.063
Suzuki N, Suzuki T, Ota Y et al (2009) Design, synthesis, and biological activity of boronic acid-based histone deacetylase inhibitors. J Med Chem 52:2909–2922. doi:10.1021/jm900125m
Xie W, Zou B, Pei D, Ma D (2005) Total synthesis of cyclic tetrapeptide FR235222, a potent immunosuppressant that inhibits mammalian histone deacetylases. Org Lett 7:2775–2777. doi:10.1021/ol050991r
Yoshida M, Kijima M, Akita M, Beppu T (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265:17174–17179
Yoshida M, Matsuayama A, Komatsu Y, Nishino N (2003) From discovery to the coming generation of histone deacetylase inhibitors. Curr Med Chem 10:2351–2358. doi:10.2174/092986708784049612
Yoshimura K, Tsubotani S, Okazaki K (1995) TAN1746 compounds, their production and use thereof. JP 7196686
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Islam, M.S., Bhuiyan, M.P.I., Islam, M.N. et al. Evaluation of functional groups on amino acids in cyclic tetrapeptides in histone deacetylase inhibition. Amino Acids 42, 2103–2110 (2012). https://doi.org/10.1007/s00726-011-0947-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-011-0947-6